Karam A - Search Results

1

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions.

Karam A, Ledermann JA, Kim JW, Sehouli J, Lu K, Gourley C, Katsumata N, Burger RA, Nam BH, Bacon M, Ng C, Pfisterer J, Bekkers RLM, Casado Herráez A, Redondo A, Fujiwara H, Gleeson N, Rosengarten O, Scambia G, Zhu J, Okamoto A, Stuart G, Ochiai K; participants of the 5th Ovarian Cancer Consensus Conference. Karam A, et al. Ann Oncol. 2017 Apr 1;28(4):711-717. doi: 10.1093/annonc/mdx011. Ann Oncol. 2017. PMID: 28327917 Free article.

2

Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer.

Karam AK, Chiang JW, Fung E, Nossov V, Karlan BY. Karam AK, et al. Gynecol Oncol. 2009 Aug;114(2):246-52. doi: 10.1016/j.ygyno.2009.02.022. Epub 2009 Jun 4. Gynecol Oncol. 2009. PMID: 19500821

3

Does omentectomy in epithelial ovarian cancer affect survival? An analysis of the Surveillance, Epidemiology, and End Results database.

McNally L, Teng NN, Kapp DS, Karam A. McNally L, et al. Among authors: karam a. Int J Gynecol Cancer. 2015 May;25(4):607-15. doi: 10.1097/IGC.0000000000000412. Int J Gynecol Cancer. 2015. PMID: 25756404

4

The role of asymptomatic screening in the detection of recurrent ovarian cancer.

Richardson MT, Routson S, Karam A, Dorigo O, Levy K, Renz M, Diver EJ. Richardson MT, et al. Among authors: karam a. Gynecol Oncol Rep. 2020 Jun 3;33:100595. doi: 10.1016/j.gore.2020.100595. eCollection 2020 Aug. Gynecol Oncol Rep. 2020. PMID: 32548232 Free PMC article.

5

Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome.

Karam AK, Santillan A, Bristow RE, Giuntoli R 2nd, Gardner GJ, Cass I, Karlan BY, Li AJ. Karam AK, et al. Gynecol Oncol. 2007 Feb;104(2):377-80. doi: 10.1016/j.ygyno.2006.08.037. Epub 2006 Oct 2. Gynecol Oncol. 2007. PMID: 17014899

6

Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.

Santillan A, Karam AK, Li AJ, Giuntoli R 2nd, Gardner GJ, Cass I, Karlan BY, Bristow RE. Santillan A, et al. Among authors: karam ak. Gynecol Oncol. 2007 Mar;104(3):686-90. doi: 10.1016/j.ygyno.2006.10.020. Epub 2006 Dec 1. Gynecol Oncol. 2007. PMID: 17141302

7

Ovarian cancer: the duplicity of CA125 measurement.

Karam AK, Karlan BY. Karam AK, et al. Nat Rev Clin Oncol. 2010 Jun;7(6):335-9. doi: 10.1038/nrclinonc.2010.44. Epub 2010 Apr 6. Nat Rev Clin Oncol. 2010. PMID: 20368726 Review.

8

MMPs in ovarian cancer as therapeutic targets.

Karam A, Dorigo O. Karam A, et al. Anticancer Agents Med Chem. 2012 Sep;12(7):764-72. doi: 10.2174/187152012802650174. Anticancer Agents Med Chem. 2012. PMID: 22292752 Review.

9

Adenocarcinoma With Breast/Adnexal and Upper Gastrointestinal Differentiation Arising in an Ovarian Mature Cystic Teratoma: A Case Report and Review of the Literature.

Wheeler L, Westhoff GL, O'Keefe MC, Kong CS, Karam A. Wheeler L, et al. Among authors: karam a. Int J Gynecol Pathol. 2016 Jan;35(1):72-7. doi: 10.1097/PGP.0000000000000218. Int J Gynecol Pathol. 2016. PMID: 26352552 Review.

10

Minimally Invasive Surgery for Gynecologic Cancers-A Cautionary Tale.

Karam A, Dorigo O. Karam A, et al. JAMA Oncol. 2020 Jul 1;6(7):991-993. doi: 10.1001/jamaoncol.2020.1617. JAMA Oncol. 2020. PMID: 32525507 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters